ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000263063.1	Avagacestat	Head and neck squamous cell carcinoma	0.000876615	Resistant
ENSG00000263063.1	Avagacestat	Lung squamous cell carcinoma	0.02176734	Resistant